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EDITORIAL
Congenital ureteral obstruction: New technology, new targets
Chronic kidney disease in childhood most often stems forming growth factor (TGF)-beta, epidermal growth
factor (EGF), smooth muscle actin, heat shock protein-from congenital abnormalities of the urinary tract. Among
these, obstructive uropathy is most common, accounting 27, clusterin, NOS, endothelin, neuropeptide Y, and ad-
renomedullin, to mention a few [11–16]. Such genes havefor approximately 16% of all cases of end-stage renal dis-
ease (ESRD) in children [1]. Over the past several de- mainly been sought as candidate genes, largely based on
their known functions. With the completion of the hu-cades, with the availability of antenatal detection of fetal
anomalies, early intervention has become a goal; early man genome project and the advent of high throughput
techniques such as array technology, it is possible to castpostnatal intervention to relieve genitourinary obstruc-
tion has become routine (and intrauterine intervention, a wider net to find other genes with altered expression.
Indeed, such new technology can both confirm the pre-occasional). However, correction of urinary tract ob-
struction has turned out to be insufficient, per se, in pre- viously observed, and, more interestingly, help in devel-
venting progression of renal dysfunction in a substantial oping testable hypotheses. The amount of data, never-
number of children with obstruction. Consequently, re- theless, is very large indeed. For example, recently,
search aimed at solving the puzzle as to why this is so Stuart et al [17] examined changes in gene expression
has occupied many investigators [2–5]. Despite a large patterns during multiple points of development and mat-
body of clinical and experimental data, many aspects of uration of the rat kidney, and reported that 873 of 8740
obstructive uropathy and why it progresses remain un- genes included in the Affymetrix U34A gene chips varied
solved. The National Institute of Diabetes and Digestive with the developmental stage.
and Kidney Diseases (NIDDK) has recently released In this issue of Kidney International, by employing
a program announcement, PA-03-076, on this subject, DNA array technology, Silverstein et al [18] present
entitled “Basic and clinical studies of congenital urinary results that are both hypothesis confirming and hypothe-
tract obstruction,” with the express purpose of stimulat- sis generating. Despite some inevitable limitations of such
ing “novel and productive research focusing on congeni- work, the results bolster several concepts about congeni-
tal urinary tract obstruction [6].” tal ureteral obstruction—that inflammation and immune
A number of experimental models in several species modulation are important in the progression of obstruc-
have been utilized to delineate the course of obstructive tive uropathy, that genes that control cytoskeleton and
uropathy, both surgically induced and spontaneous [2–4, extracellular matrix are affected in severe obstruction,
7–10]. Among these, unilateral ureteral obstruction and that multiple other genes are increased or decreased
(UUO) in the neonatal rat has been a widely studied in their expression. The results are provocative and thus
model, as producing the lesion is straightforward, if tech- should be, among other things, hypothesis generating.
nically demanding. UUO is an attractive model, since Results from studies utilizing array technology require
nephrogenesis in the rat extends throughout the first confirmation by other techniques. While Silverstein et al
postnatal weeks. An issue with this model, however, is [18] did not employ semi-quantitative or real-time reverse
the fact that onset of obstruction is surgical, and most transcription polymerase chain reaction (RT-PCR), or
human cases of obstructive uropathy are not of such Northern analysis to confirm levels of mRNA expression,
sudden onset. Thus, models in which onset is spontane- they used Western analysis to assess involvement of the
ous [4] also have appeal, though these are less completely products of 10 immunoregulatory genes that appeared
studied. Irrespective of the model, a final common path- up-regulated on the array studies. They found increased
way seems to be progression of renal dysfunction over protein expression of these genes of interest, strongly
time, even after obstruction has been relieved. suggesting that the array findings had functional signifi-
There is consensus that severe obstructive uropathy cance in their model.
interferes with renal development, a complex interaction Many of the findings of Silverstein et al [18] are con-
of inductive events, communication between cells, and firmatory, which is reassuring, given the fact that the
proliferation. The expression and function of number of array they utilized contained genes already known to be
candidate genes and systems are already known to be involved in UUO. The authors report that they found
involved in congenital obstructive uropathy, for example, an increase in a number of genes previously shown to
renin, angiotensin receptors, the kininogen family, trans- have altered expression in neonatal UUO, including clus-
terin, EGF, HSP-27, renin, smooth muscle actin, and
TGF-beta. They also observed increases or decreases in
some 250 genes, some of which were not previously 2003 by the International Society of Nephrology
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